Author: Karamjit Singh

Week in Review: Fueling the dreams of start-ups
Funding from both public and private money helps fire up entrepreneurs with big dreams, writes DNA founder and CEO Karamjit Singh.
Disrupt #5: Follow the money, with Grove and Jamaludin
Next week’s Disrupt on Wed the 20th at Plug and Play Technologies Sdn Bhd, 7th Floor South Tower, Gardens, is all about the money. Who is giving it out, and what the funders like in the ideas and the entrepreneurs.
Piktochart sets ‘scary target’ for 2013
With the launch of its new version, infographics start-up Piktochart hopes to grow its user base by nearly 10 times in 2013 while attracting a US$1-million investment.
Maxis adopts hook strategy with LTE
With Maxis taking a market leadership position in LTE rollout in Malaysia, it is timely to ask two questions: Will the LTE market be a handset-dominated one? And will Maxis adopt a premium positioning? Karamjit Singh explores the issue.
Week in Review: Penang no longer just about MNCs
Multinationals still dominate the Penang landscape, but now local companies are fighting for the top engineers too, writes DNA founder and CEO Karamjit Singh.
Taxi-booking app space heats up; Sunlight to launch its own
Sunlight Unicablink will officially launch its Book-a-Cab taxi booking app this week, the first can company to go it alone instead of working with start-ups. With other cab companies looking into launching apps too, the winners will be the ones who deliver the best service to customers, argues Karamjit Singh.
Week in Review: We’re all going to be watching Matt Chandran
This week’s highlight could not be anything other than AIM’s US$22.7 million investment into iGene Sdn Bhd, perhaps the largest venture capital investment ever made into a Malaysian company.
Frustration the trigger for success at iGene
iGene CEO Matt Chandran was doing well providing consultancy and selling a bioinformatics software solution to clients when it hit him that clients 'did not have the will to tap the power of our software to its maximum potential.' That led to his company building on it to deliver its own service.
AIM takes 12% stake in US cardiac device start-up
AIM makes its second venture investment with a stake of around 12% in US cardiac device start-up which will use KL as its Asian Hq and center of excellence.
Enterprise-centric Disrupt a pleasant surprise
The nice mix of seasoned entrepreneurs, eager start-ups and corporate types at Disrupt pleases DNA founder Karamjit Singh, as does the enterprise-centric discussion that ensued.
Download Digerati50 2020-2021 PDF

Digerati50 2020-2021

Get and download a digital copy of Digerati50 2020-2021